| Record ID | marc_loc_2016/BooksAll.2016.part22.utf8:165430834:1317 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part22.utf8:165430834:1317?format=raw |
LEADER: 01317cam a2200325 a 4500
001 93020752
003 DLC
005 19931012081808.2
008 930713s1993 nyua b 101 0 eng c
010 $a 93020752 //r93
020 $a0897668251 (cloth : alk. paper)
020 $a089766826X (paper : alk. paper)
040 $aDNLM/DLC$cDLC$dDLC
050 00 $aQ11$b.N5 vol. 690$aRC271.I45
060 00 $aW1 AM626YL v.690 1993$aQZ 266 S741 1993
082 00 $a616.99/406$220
245 00 $aSpecific immunotherapy of cancer with vaccines /$cedited by Jean-Claude Bystryn, Soldano Ferrone, and Philip Livingston.
260 $aNew York, N.Y. :$bNew York Academy of Sciences,$c1993.
300 $axii, 411 p. :$bill. ;$c24 cm.
440 0 $aAnnals of the New York Academy of Sciences,$x0077-8923 ;$vv. 690
500 $aProceedings of a conference held by the New York Academy of Sciences, Jan. 21-24, 1993, in Washington, D.C.
504 $aIncludes bibliographical references and index.
650 0 $aCancer$xImmunotherapy$xCongresses.
650 0 $aVaccines$xCongresses.
650 2 $aNeoplasms$xtherapy$xcongresses.
650 2 $aImmunotherapy, Active$xcongresses.
700 10 $aBystryn, Jean-Claude.
700 10 $aFerrone, Soldano,$d1940-
700 10 $aLivingston, Philip.
710 20 $aNew York Academy of Sciences.